STOCK TITAN

111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

111, Inc. (NASDAQ: YI) has expanded its national supply chain network with new fulfillment centers in Guangzhou and Wuhan. These additions bring the total number of centers to 13 across China, enhancing the company's warehousing and distribution capabilities. The new centers utilize an innovative operational model that reduces costs and improves efficiency, enabling 24-hour deliveries in most South and Central China markets.

The expansion strengthens 111's nationwide logistics network, 'Kunpeng,' which has reduced delivery costs by 15% and damage rates by 55%. The company's smart supply chain management systems, powered by over 30 self-developed technologies, support these operations. 111's virtual pharmacy network now serves approximately 470,000 pharmacies and partners with over 500 global pharmaceutical companies and 4,500 distributors.

111, Inc. (NASDAQ: YI) ha ampliato la sua rete di supply chain nazionale con nuovi centri di evasione a Guangzhou e Wuhan. Queste aggiunte portano il numero totale di centri a 13 in tutta la Cina, migliorando le capacità di stoccaggio e distribuzione dell'azienda. I nuovi centri adottano un modello operativo innovativo che riduce i costi e migliora l'efficienza, permettendo consegne 24 ore su 24 nella maggior parte dei mercati del sud e del centro Cina.

L'ampliamento rafforza la rete logistica nazionale di 111, 'Kunpeng,' che ha ridotto i costi di consegna del 15% e i tassi di danneggiamento del 55%. I sistemi di gestione della supply chain intelligenti dell'azienda, basati su oltre 30 tecnologie sviluppate internamente, supportano queste operazioni. La rete di farmacie virtuali di 111 serve ora circa 470.000 farmacie e collabora con oltre 500 aziende farmaceutiche globali e 4.500 distributori.

111, Inc. (NASDAQ: YI) ha ampliado su red nacional de cadena de suministro con nuevos centros de cumplimiento en Guangzhou y Wuhan. Estas adiciones elevan el número total de centros a 13 en toda China, mejorando las capacidades de almacenamiento y distribución de la empresa. Los nuevos centros utilizan un modelo operativo innovador que reduce costos y mejora la eficiencia, permitiendo entregas las 24 horas en la mayoría de los mercados del sur y centro de China.

La expansión refuerza la red logística nacional de 111, 'Kunpeng,' que ha reducido los costos de entrega en un 15% y las tasas de daño en un 55%. Los sistemas de gestión de cadena de suministro inteligentes de la empresa, impulsados por más de 30 tecnologías desarrolladas internamente, apoyan estas operaciones. La red de farmacias virtuales de 111 ahora sirve aproximadamente a 470,000 farmacias y colabora con más de 500 empresas farmacéuticas globales y 4,500 distribuidores.

111, Inc. (NASDAQ: YI)는 광저우와 우한에 새로운 물류 센터를 추가하여 국가 공급망 네트워크를 확장했습니다. 이 추가로 중국 전역에 총 13개의 센터가 있으며, 회사의 창고 및 유통 능력이 향상되었습니다. 새 센터는 비용을 줄이고 효율성을 개선하는 혁신적인 운영 모델을 활용하여, 중국 남부 및 중부 시장의 대부분에서 24시간 배송을 가능하게 합니다.

이번 확장은 111의 전국 물류 네트워크 '쿤펑'을 강화하며, 이는 배송 비용을 15% 줄이고 손상 비율을 55% 낮췄습니다. 30개 이상의 자사 개발 기술로 지원되는 회사의 스마트 공급망 관리 시스템이 이러한 운영을 지원합니다. 111의 가상 약국 네트워크는 현재 약 470,000개의 약국을 운영하며, 500개 이상의 글로벌 제약 회사 및 4,500명의 유통업체와 협력하고 있습니다.

111, Inc. (NASDAQ: YI) a étendu son réseau national de chaîne d'approvisionnement avec de nouveaux centres de traitement à Guangzhou et Wuhan. Ces ajouts portent le nombre total de centres à 13 à travers la Chine, améliorant les capacités d'entreposage et de distribution de l'entreprise. Les nouveaux centres utilisent un modèle opérationnel innovant qui réduit les coûts et améliore l'efficacité, permettant des livraisons 24 heures sur 24 dans la plupart des marchés du sud et du centre de la Chine.

Cette expansion renforce le réseau logistique national de 111, 'Kunpeng,' qui a réduit les coûts de livraison de 15 % et les taux de dommages de 55 %. Les systèmes de gestion de la chaîne d'approvisionnement intelligents de l'entreprise, alimentés par plus de 30 technologies développées en interne, soutiennent ces opérations. Le réseau de pharmacies virtuelles de 111 dessert maintenant environ 470 000 pharmacies et collabore avec plus de 500 entreprises pharmaceutiques mondiales et 4 500 distributeurs.

111, Inc. (NASDAQ: YI) hat sein nationales Lieferkettennetzwerk mit neuen Fulfillment-Zentren in Guangzhou und Wuhan erweitert. Diese Ergänzungen erhöhen die Gesamtzahl der Zentren auf 13 in ganz China und verbessern die Lager- und Vertriebskapazitäten des Unternehmens. Die neuen Zentren nutzen ein innovatives Betriebsmodell, das Kosten senkt und die Effizienz steigert, was 24-Stunden-Lieferungen in den meisten Märkten in Süd- und Zentralchina ermöglicht.

Die Expansion stärkt das landesweite Logistiknetzwerk von 111, 'Kunpeng', das die Lieferkosten um 15 % und die Schadensquoten um 55 % gesenkt hat. Die intelligenten Systeme des Unternehmens für das Lieferkettenmanagement, die auf über 30 selbstentwickelten Technologien basieren, unterstützen diese Operationen. Das virtuelle Apothekennetzwerk von 111 bedient jetzt etwa 470.000 Apotheken und arbeitet mit über 500 globalen Pharmaunternehmen und 4.500 Distributoren zusammen.

Positive
  • Expansion of fulfillment centers to 13 across China, improving national coverage
  • New operational model reduces costs and improves efficiency
  • 24-hour delivery capability in most South and Central China markets
  • 15% reduction in delivery costs and 55% reduction in damage rates
  • Virtual pharmacy network serving 470,000 pharmacies
  • Partnerships with over 500 global pharmaceutical companies and 4,500 distributors
Negative
  • None.

Insights

The expansion of 111's fulfillment network with new centers in Guangzhou and Wuhan is a strategic move to enhance operational efficiency and market reach. This brings their total fulfillment centers to 13 across China, significantly improving their ability to serve the vast Chinese market. The new operational model is designed to reduce costs while expanding capacity, which should positively impact the company's bottom line.

Key improvements include:

  • 24-hour delivery to over 300 major cities
  • 15% reduction in delivery costs
  • 55% decrease in delivery damage rates

These enhancements address critical industry challenges and position 111 as a more competitive player in the healthcare supply chain. The company's virtual pharmacy network, serving 470,000 pharmacies and partnering with 500 global pharmaceutical companies, demonstrates its growing influence in the sector. However, investors should monitor how these expansions translate into revenue growth and profitability in the coming quarters.

111's investment in technological innovation is a important differentiator in the competitive healthcare platform market. The company's suite of over 30 self-developed technologies for supply chain management showcases its commitment to digital transformation. This tech-driven approach enables:

  • Smart inventory management
  • Optimized distribution
  • Dynamic pricing strategies

The "Kunpeng" logistics network, leveraging digitalized long-haul and last-mile distribution models, is particularly noteworthy. It not only improves operational efficiency but also creates a significant barrier to entry for potential competitors. The integration of these technologies with the expanded fulfillment network positions 111 to potentially disrupt traditional pharmaceutical distribution channels.

Investors should consider the long-term value of these technological assets and their potential to drive sustained competitive advantage. However, it's important to assess the ongoing R&D costs and the pace of technology adoption in the industry to fully gauge the impact on 111's market position and financial performance.

SHANGHAI, Oct. 10, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that new fulfillment centers in South and Central China began operations in Guangzhou, Guangdong Province, and Wuhan, Hubei Province, respectively. These strategic expansions mark a significant step forward in enhancing its national supply chain network, increasing efficiency and speed to better meet growing market demand.

The two new centers expand the scale and capabilities of 111's existing operations in the South and Central China regions. With innovation and technological upgrades, the centers enable faster and more efficient operations. The additional fulfillment centers bring the total number in 111 operations to 13 across China, ensuring a more robust and agile warehousing and distribution network nationwide.

By utilizing a newly designed operational model, these centers will significantly reduce operating costs while expanding warehousing capacity with higher cost efficiency. This will also improve the efficiency of operations and deliveries in the South and Central China markets, with most deliveries now being fulfilled within 24 hours. With a stronger national supply chain network, 111 is well positioned to deliver to over 300 major cities nationwide within 24 hours and cover the entire nation within 72 hours.

Additionally, 111's nationwide logistics network, "Kunpeng," continues to improve operational efficiency by streamlining connections between fulfillment centers through its digitalized long-haul and last-mile distribution models. As a result, delivery costs have been slashed by 15%, and delivery damage rates have been cut by 55%. These improvements address key industry challenges, such as slow delivery times, high damage rates and inefficient quality control processes, while providing seamless logistics services to partners across the supply chain.

111's continuous technological innovation empowers its smart supply chain management systems as core drivers of success. These systems, among the most complex in 111's digital suite, support the Company's nationwide supply chain operations and include over 30 self-developed technologies ranging from procurement and inventory management to distribution and pricing.

The innovative supply chain and logistics network, combined with smart management systems, underpins 111's nationwide virtual pharmacy network, a key outcome from its industrial internet strategy. This virtual network currently serves approximately 470,000 pharmacies and boasts partnerships with over 500 global pharmaceutical companies and 4,500 distributors, underscoring the Company's growing influence in the healthcare and pharmaceutical industries.

Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, commented, "The opening of our new fulfillment centers in South and Central China is critical in strengthening our supply chain and delivering exceptional service to our customers. By integrating cutting-edge technology and operational innovation, we are now able to further enhance our delivery speed, reduce costs, and improve overall efficiency. These centers not only reinforce our market presence in key regions but also support our vision of becoming the go-to platform for pharmaceutical products with the best selection as well as prices across China. As we continue to scale up, we remain focused on driving operational excellence and creating long-term value for our partners, customers, and shareholders."

Forward-Looking Statements

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident" and similar statements. 111 may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control. Forward-looking statements involve inherent risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. Potential risks and uncertainties include, but are not limited to, uncertainties as to the Company's ability comply with extensive and evolving regulatory requirements, its ability to compete effectively in the evolving PRC general health and wellness market, its ability to manage the growth of its business and expansion plans, its ability to achieve or maintain profitability in the future, its ability to control the risks associated with its pharmaceutical retail and wholesale businesses, and the Company's ability to meet the standards necessary to maintain listing of its ADSs on the Nasdaq Global Market, including its ability to cure any non-compliance with Nasdaq's continued listing criteria. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and 111 does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

About 111, Inc.

111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company's online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.

For more information on 111, please visit: http://ir.111.com.cn/

Cision View original content:https://www.prnewswire.com/news-releases/111-inc-expands-national-supply-chain-network-with-new-fulfillment-centers-across-south-and-central-china-302272803.html

SOURCE 111, Inc.

FAQ

How many new fulfillment centers did 111 Inc. (YI) open in October 2024?

111 Inc. opened two new fulfillment centers in October 2024, located in Guangzhou, Guangdong Province, and Wuhan, Hubei Province.

What is the total number of fulfillment centers 111 Inc. (YI) now operates in China?

With the addition of the new centers, 111 Inc. now operates a total of 13 fulfillment centers across China.

How has 111 Inc.'s (YI) 'Kunpeng' logistics network improved delivery efficiency?

The 'Kunpeng' logistics network has reduced delivery costs by 15% and cut delivery damage rates by 55%.

How many pharmacies does 111 Inc.'s (YI) virtual pharmacy network serve?

111 Inc.'s virtual pharmacy network currently serves approximately 470,000 pharmacies.

111, Inc. American Depositary Shares

NASDAQ:YI

YI Rankings

YI Latest News

YI Stock Data

64.42M
33.71M
16.16%
23.9%
0.04%
Medical Distribution
Healthcare
Link
United States of America
Shanghai